call Toll Free (US/Canada): +1 866 658 6826 | call+1 425 320 4776 | call (UK): +44 1865 60 0662 | call (Ind): +91 9096278110 | email info(@)blueweaveconsulting.com
Home | About Us | Career | Services | Blog | Contact Us
Blueweave
Antimicrobial Resistance Surveillance Market
Inquire Before Buying Request for Sample

Antimicrobial Resistance Surveillance Market

Home Healthcare And Pharmaceutical Antimicrobial Resistance Surveillance Market

Antimicrobial Resistance Surveillance Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Solution (Diagnostic Kits, Diagnostic Systems, Surveillance Software, Services); By Application (Clinical Diagnostics, Public Health Surveillance); By End User (Hospitals & Clinics, Research & Academic Institutes); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

  • Published Date: December 2023
  • Report ID: BWC231035
  • Available Format: PDF
  • Page: 400

Report Overview

Growing incidences of hospital-acquired infections driving the increasing adoption of innovative diagnostic techniques are projected to propel the expansion of the Global Antimicrobial Resistance Surveillance Market during the forecast period between 2023 and 2029.

Global Antimicrobial Resistance Surveillance Market - Industry Trends & Forecast Report, 2029

Global Antimicrobial Resistance Surveillance Market size was estimated at USD  5.71 billion in 2022. During the forecast period between 2023 and 2029, the size of Global Antimicrobial Resistance Surveillance Market is projected to grow at a CAGR of 5.6% reaching a value of USD 7.92 billion by 2029. Major growth drivers for the Global Antimicrobial Resistance Surveillance Market include increasing incidences of infections attributed to drug-resistant pathogens, advancements in diagnostic technologies, a rising concern over antimicrobial resistance, governmental efforts to address antimicrobial resistance, and the emergence of multi-drug resistance linked to drug abuse. Notably, advanced imaging technologies now deliver clinical information swiftly, contrasting with traditional culture-based methods taking up to 48 hours for susceptibility data. The Emergence Of New Techniques Detecting Drug Resistance Without Lengthy Culture processes shortens the diagnostic timeframe by at least a day. Faster and more advanced diagnostic tests are expected to drive the antimicrobial resistance diagnostics market. Also, nosocomial infections, acquired during hospitalization, encompass diverse illnesses. Hospital-acquired infections, such as central line-associated bloodstream infections and urinary tract infections from catheters, are widespread. The prevalence of these infections is poised to boost the antimicrobial resistance diagnostics market, reflecting the growing use of invasive techniques and equipment in modern healthcare.

Antimicrobial Resistance Surveillance Market

Antimicrobial Resistance Surveillance – Overview

Antimicrobial resistance (AMR) is a pressing public health issue, necessitating a robust global market. When microorganisms resist medications, treatment efficacy diminishes. The growing Global Antimicrobial Resistance Surveillance Market addresses the urgent need for surveillance systems to monitor AMR spread, enabling informed decisions on antibiotic prescriptions. Key components include advanced laboratory techniques, data analytics, and information-sharing platforms, collecting and analyzing global data. This approach empowers healthcare stakeholders to detect resistance patterns, implement targeted interventions, and innovate antimicrobial therapies.

Global Antimicrobial Resistance Surveillance Market

Growth Drivers

Increasing Incidences of Hospital-Acquired Infections

The escalating prevalence of hospital-acquired infections, commonly termed nosocomial infections, stands out as a crucial factor propelling the growth of the antimicrobial resistance diagnostics market. These infections encompass diverse types, including central line-associated bloodstream infections, urinary tract infections stemming from catheter use, various surgical site infections, ventilator-associated pneumonia, and infections caused by Clostridioides difficile (CD). The modern healthcare landscape, characterized by the application of invasive techniques and equipment, contributes significantly to the heightened occurrence of these infections. Consequently, the increasing incidences of hospital-acquired infections emerge as a noteworthy driver fostering the expansion of the antimicrobial resistance diagnostics market.

Restraints

High Costs associated with Antimicrobial Resistance Surveillance System and Kits

The Global Antimicrobial Resistance Surveillance Market growth faces a hindrance due to the substantial costs linked with surveillance systems and kits. The financial burden associated with implementing and maintaining these systems acts as a significant restraint, limiting widespread adoption. The high costs pose challenges for healthcare institutions and organizations aiming to invest in comprehensive antimicrobial resistance surveillance, thereby impacting the overall growth prospects of the market.

Global Antimicrobial Resistance Surveillance Market

Segmental Coverage

Global Antimicrobial Resistance Surveillance Market – By Solution

Based on solution, the Global Antimicrobial Resistance Surveillance Market is divided into Diagnostic Kits, Diagnostic Systems, Surveillance Software, and Services segments. The diagnostics kits segment holds the highest share in the Global Antimicrobial Resistance Surveillance Market by solution. It is primarily due to the growing requirement for prompt identification and treatment, the escalating demand for swift diagnostics concerning antimicrobial resistance, and the necessity for essential data for the surveillance and monitoring of trends related to antimicrobial resistance.

Global Antimicrobial Resistance Surveillance Market – By Application

Based on application, the Global Antimicrobial Resistance Surveillance Market is bifurcated into Clinical Diagnostics and Public Health Surveillance segments. The clinical diagnostics segment holds a higher share in the Global Antimicrobial Resistance Surveillance Market by application. It can be attributed to the growing inclination toward improved patient outcomes and the rising prevalence of antimicrobial resistance.

Antimicrobial Resistance Surveillance Market Share

Global Antimicrobial Resistance Surveillance Market – By End User

On the basis of end user, the Global Antimicrobial Resistance Surveillance Market is split into Hospitals & Clinics and Research & Academic Institutes segments. The hospitals & clinics segment holds a higher share in the Global Antimicrobial Resistance Surveillance Market by end user, due to the elevated patient density observed in hospitals and clinics, the rising incidence of nosocomial infections within hospital settings, and the imperative to uphold stringent infection control protocols.

Antimicrobial Resistance Surveillance Market Size

Global Antimicrobial Resistance Surveillance Market – By Region

The in-depth research report on the Global Antimicrobial Resistance Surveillance Market covers various country-specific markets across five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America region holds the highest share in the Global Antimicrobial Resistance Surveillance Market. The region's dominance is attributed to its well-established healthcare systems and advanced laboratory facilities in the United States and Canada. These nations exhibit substantial investments in antimicrobial resistance (AMR) surveillance, with a specific focus on clinical diagnostics and data collection. The region's robust healthcare infrastructure and high standards of patient care contribute to the significant share held by clinical diagnostics in North America. Notably, the Centers for Disease Control and Prevention (CDC) in the United States spearhead AMR surveillance efforts. Meanwhile, the Asia Pacific region is expected to witness the fastest growth rate during the forecast period. China, in particular, has made noteworthy investments in AMR surveillance, establishing a national data collection network. Collaboration with international organizations, such as the World Health Organization (WHO), further enhances the region's efforts. The Asia Pacific region, encompassing diverse healthcare systems and population sizes, including China and India, encounters distinct challenges, prompting an upsurge in public health surveillance initiatives facilitated by regional and global health organizations

Competitive Landscape

Major players operating in the Global Antimicrobial Resistance Surveillance Market include Becton, Dickinson and Company, Biomerieux, Thermo Fisher Scientific, Danaher, Luminex Corporation, Bruker, Bio-Rad, Qiagen, Abbott Laboratories, Roche Diagnostics, OpGen, Inc., Wolters Kluwer N.V., Lumed, BioSpace, and Cepheid. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Recent Developments

  • In August 2023 - The UK Government pledged GBP 210 million to combat antimicrobial resistance (AMR) in priority countries across Asia and Africa. The funding, part of The Fleming Fund’s global AMR surveillance program, will establish state-of-the-art laboratories, disease surveillance systems, and support workforce development. Aimed at identifying superbugs before they reach the UK, the investment includes 20,000 training sessions for laboratory staff and health professionals in 25 countries with high AMR threats. Additionally, over 200 Fleming Fund Scholarships will enhance expertise in AMR. The UK-India partnership, backed by a GBP 3 million investment, contributes to strengthening global efforts against the silent threat of AMR, which could cause ten million deaths by 2050 if left unchecked.

  • In April 2023 - BioMérieux and JMI Laboratories forged a six-year partnership to combat antimicrobial resistance (AMR). The collaboration seeks to assess and enhance the performance of rapid microbiology diagnostics, essential tools in the battle against AMR. BioMérieux, known globally for its diagnostic advancements, will collaborate with JMI, a leader in antimicrobial resistance monitoring studies. The partnership aims to continuously evaluate antimicrobial susceptibility testing results against evolving global data through JMI's SENTRY program, contributing to understanding resistance mechanisms and improving the detection of resistance factors worldwide.

Scope of the Report

Attributes

Details

Years Considered

Historical Data – 2019–2022

Base Year – 2022

Estimated Year – 2023

Forecast Period – 2023–2029

Facts Covered

Revenue in USD Billion

Market Coverage

North America, Europe, Asia Pacific, Latin America, Middle East and Africa

Product/ Service Segmentation

Solution, Application, End User, Region

Key Players

Becton, Dickinson and Company, Biomerieux, Thermo Fisher Scientific, Danaher, Luminex Corporation, Bruker, Bio-Rad, Qiagen, Abbott Laboratories, Roche Diagnostics, OpGen, Inc., Wolters Kluwer N.V., Lumed, BioSpace, Cepheid

 

By Solution

  • Diagnostic kits

  • Diagnostic systems

  • Surveillance software

  • Services

By Application

  • Clinical Diagnostics

  • Public Health Surveillance

By End User

  • Hospitals & Clinics

  • Research & Academic Institutes

By Region

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East and Africa

 
  1. Research Framework
    1. Research Objective
    2. Product Overview
    3. Market Segmentation
  2. Executive Summary
  3.  Global Antimicrobial Resistance Surveillance Market Insights
    1. Industry Value Chain Analysis
    2. DROC Analysis
      1. Growth Drivers
        1. Increasing innovation in diagnostic technologies
        2. Increasing incidences of hospital-acquired infections
      2. Restraints
        1. High costs associated with antimicrobial resistance surveillance system and kits
        2. Technical challenges in the End User
      3. Opportunities
        1. Awareness initiatives for antimicrobial resistance and control
        2. Growth opportunities in emerging economies
      4. Challenges
        1. Complex regulatory framework
    3. Technological Advancements/Recent Developments
    4. Regulatory Framework
    5. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
  4. Global Antimicrobial Resistance Surveillance Market Overview
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share and Forecast
      1. By Solution
        1. Diagnostic kits
        2. Diagnostic systems
        3. Surveillance software
        4. Services
      2. By Application
        1. Clinical Diagnostics
        2. Public Health Surveillance
        3. Other
      3. By End User
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Others
      4. By Region
        1. North America
        2. Europe
        3. Asia Pacific (APAC)
        4. Latin America (LATAM)
        5. Middle East and Africa (MEA)
  5. North America Antimicrobial Resistance Surveillance Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Solution
      2. By Application
      3. By End User
      4. By Country
        1. United States
          1. By Solution
          2. By Application
          3. By End User
        2. Canada
          1. By Solution
          2. By Application
          3. By End User
  6. Europe Antimicrobial Resistance Surveillance Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Solution
      2. By Application
      3. By End User
      4. By Country
        1. Germany
          1. By Solution
          2. By Application
          3. By End User
        2. United Kingdom
          1. By Solution
          2. By Application
          3. By End User
        3. Italy
          1. By Solution
          2. By Application
          3. By End User
        4. France
          1. By Solution
          2. By Application
          3. By End User
        5. Spain
          1. By Solution
          2. By Application
          3. By End User
        6. Belgium
          1. By Solution
          2. By Application
          3. By End User
        7. Russia
          1. By Solution
          2. By Application
          3. By End User
        8. The Netherlands
          1. By Solution
          2. By Application
          3. By End User
        9. Rest of Europe
          1. By Solution
          2. By Application
          3. By End User
  7. Asia Pacific Antimicrobial Resistance Surveillance Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Solution
      2. By Application
      3. By End User
      4. By Country
        1. China
          1. By Solution
          2. By Application
          3. By End User
        2. India
          1. By Solution
          2. By Application
          3. By End User
        3. Japan
          1. By Solution
          2. By Application
          3. By End User
        4. South Korea
          1. By Solution
          2. By Application
          3. By End User
        5. Australia & New Zealand
          1. By Solution
          2. By Application
          3. By End User
        6. Indonesia
          1. By Solution
          2. By Application
          3. By End User
        7. Malaysia
          1. By Solution
          2. By Application
          3. By End User
        8. Singapore
          1. By Solution
          2. By Application
          3. By End User
        9. Vietnam
          1. By Solution
          2. By Application
          3. By End User
        10. Rest of APAC
          1. By Solution
          2. By Application
          3. By End User
  8. Latin America Antimicrobial Resistance Surveillance Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Solution
      2. By Application
      3. By End User
      4. By Country
        1. Brazil
          1. By Solution
          2. By Application
          3. By End User
        2. Mexico
          1. By Solution
          2. By Application
          3. By End User
        3. Argentina
          1. By Solution
          2. By Application
          3. By End User
        4. Peru
          1. By Solution
          2. By Application
          3. By End User
        5. Rest of LATAM
          1. By Solution
          2. By Application
          3. By End User
  9. Middle East & Africa Antimicrobial Resistance Surveillance Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Solution
      2. By Application
      3. By End User
      4. By Country
        1. Saudi Arabia
          1. By Solution
          2. By Application
          3. By End User
        2. UAE
          1. By Solution
          2. By Application
          3. By End User
        3. Qatar
          1. By Solution
          2. By Application
          3. By End User
        4. Kuwait
          1. By Solution
          2. By Application
          3. By End User
        5. South Africa
          1. By Solution
          2. By Application
          3. By End User
        6. Nigeria
          1. By Solution
          2. By Application
          3. By End User
        7. Algeria
          1. By Solution
          2. By Application
          3. By End User
        8. Rest of MEA
          1. By Solution
          2. By Application
          3. By End User
  10. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. Global Antimicrobial Resistance Surveillance Market Share Analysis, 2022
    3. Competitive Benchmarking, By Operating Parameters
    4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
  11. Impact of Covid-19 on Global Antimicrobial Resistance Surveillance Market
  12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
    1. Becton, Dickinson and Company
    2. Biomerieux
    3. Thermo Fisher Scientific
    4. Danaher
    5. Luminex Corporation
    6. Bruker
    7. Bio-Rad
    8. Qiagen
    9. Abbott Laboratories
    10. Roche Diagnostics
    11. OpGen, Inc.
    12. Wolters Kluwer N.V.
    13. Lumed
    14. BioSpace
    15. Cepheid
    16. Other Prominent Players
  13. Key Strategic Recommendations
  14. Research Methodology
    1.    Qualitative Research
      1.  Primary & Secondary Research
    2.    Quantitative Research
    3.    Market Breakdown & Data Triangulation
      1.  Secondary Research
      2.  Primary Research
    4.    Breakdown of Primary Research Respondents, By Region
    5.    Assumptions & Limitations

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable

 

List of Figures

Figure 1       Global Antimicrobial Resistance Surveillance Segmentation

Figure 2       Global Antimicrobial Resistance Surveillance Market Value Chain Analysis

Figure 3       Company Market Share Analysis, 2022

Figure 4       Global Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 5       Global Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 6       Global Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 7       Global Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 8       Global Antimicrobial Resistance Surveillance Market Share, By Region, By Value, 2019–2029

Figure 9       North America Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 10     North America Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 11     North America Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 12     North America Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 13     North America Antimicrobial Resistance Surveillance Market Share, By Country, By Value, 2019–2029

Figure 14     United States Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 15     United States Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 16     United States Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 17     United States Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 18     Canada Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 19     Canada Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 20     Canada Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 21     Canada Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 22     Europe Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 23     Europe Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 24     Europe Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 25     Europe Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 26     Europe Antimicrobial Resistance Surveillance Market Share, By Country, By Value, 2019–2029

Figure 27     Germany Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 28     Germany Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 29     Germany Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 30     Germany Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 31     United Kingdom Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 32     United Kingdom Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 33     United Kingdom Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 34     United Kingdom Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 35     Italy Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 36     Italy Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 37     Italy Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 38     Italy Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 39     France Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 40     France Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 41     France Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 42     France Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 43     Spain Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 44     Spain Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 45     Spain Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 46     Spain Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 47     Belgium Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 48     Belgium Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 49     Belgium Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 50     Belgium Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 51     Russia Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 52     Russia Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 53     Russia Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 54     Russia Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 55     The Netherlands Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 56     The Netherlands Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 57     The Netherlands Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 58     The Netherlands Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 59     Rest of Europe Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 60     Rest of Europe Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 61     Rest of Europe Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 62     Rest of Europe Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 63     Asia Pacific Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 64     Asia Pacific Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 65     Asia Pacific Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 66     Asia Pacific Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 67     Asia Pacific Antimicrobial Resistance Surveillance Market Share, By Country, By Value, 2019–2029

Figure 68     China Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 69     China Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 70     China Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 71     China Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 72     India Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 73     India Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 74     India Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 75     India Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 76     Japan Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 77     Japan Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 78     Japan Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 79     Japan Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 80     South Korea Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 81     South Korea Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 82     South Korea Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 83     South Korea Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 84     Australia & New Zealand Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 85     Australia & New Zealand Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 86     Australia & New Zealand Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 87     Australia & New Zealand Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 88     Indonesia Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 89     Indonesia Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 90     Indonesia Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 91     Indonesia Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 92     Malaysia Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 93     Malaysia Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 94     Malaysia Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 95     Malaysia Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 96     Singapore Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 97     Singapore Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 98     Singapore Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 99     Singapore Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 100   Vietnam Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 101   Vietnam Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 102   Vietnam Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 103   Vietnam Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 104   Rest of APAC Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 105   Rest of APAC Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 106   Rest of APAC Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 107   Rest of APAC Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 108   Latin America Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 109   Latin America Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 110   Latin America Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 111   Latin America Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 112   Latin America Antimicrobial Resistance Surveillance Market Share, By Country, By Value, 2019–2029

Figure 113   Brazil Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 114   Brazil Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 115   Brazil Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 116   Brazil Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 117   Mexico Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 118   Mexico Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 119   Mexico Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 120   Mexico Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 121   Argentina Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 122   Argentina Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 123   Argentina Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 124   Argentina Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 125   Peru Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 126   Peru Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 127   Peru Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 128   Peru Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 129   Rest of LATAM Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 130   Rest of LATAM Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 131   Rest of LATAM Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 132   Rest of LATAM Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 133   Middle East and Africa Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 134   Middle East and Africa Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 135   Middle East and Africa Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 136   Middle East and Africa Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 137   Middle East and Africa Antimicrobial Resistance Surveillance Market Share, By Country, By Value, 2019–2029

Figure 138   Saudi Arabia Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 139   Saudi Arabia Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 140   Saudi Arabia Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 141   Saudi Arabia Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 142   UAE Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 143   UAE Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 144   UAE Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 145   UAE Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 146   Qatar Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 147   Qatar Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 148   Qatar Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 149   Qatar Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 150   Kuwait Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 151   Kuwait Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 152   Kuwait Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 153   Kuwait Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 154   South Africa Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 155   South Africa Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 156   South Africa Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 157   South Africa Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 158   Nigeria Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 159   Nigeria Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 160   Nigeria Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 161   Nigeria Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 162   Algeria Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 163   Algeria Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 164   Algeria Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 165   Algeria Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 166   Rest of MEA Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 167   Rest of MEA Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 168   Rest of MEA Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 169   Rest of MEA Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

 

List of Tables

 

Table 1        Global Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 2        Global Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 3        Global Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 4        Global Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 5        Global Antimicrobial Resistance Surveillance Market Share, By Region, By Value, 2019–2029

Table 6        North America Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 7        North America Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 8        North America Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 9        North America Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 10      North America Antimicrobial Resistance Surveillance Market Share, By Country, By Value, 2019–2029

Table 11      United States Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 12      United States Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 13      United States Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 14      United States Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 15      Canada Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 16      Canada Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 17      Canada Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 18      Canada Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 19      Europe Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 20      Europe Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 21      Europe Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 22      Europe Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 23      Europe Antimicrobial Resistance Surveillance Market Share, By Country, By Value, 2019–2029

Table 24      Germany Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 25      Germany Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 26      Germany Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 27      Germany Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 28      United Kingdom Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 29      United Kingdom Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 30      United Kingdom Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 31      United Kingdom Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 32      Italy Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 33      Italy Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 34      Italy Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 35      Italy Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 36      France Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 37      France Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 38      France Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 39      France Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 40      Spain Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 41      Spain Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 42      Spain Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 43      Spain Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 44      Belgium Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 45      Belgium Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 46      Belgium Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 47      Belgium Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 48      Russia Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 49      Russia Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 50      Russia Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 51      Russia Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 52      The Netherlands Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 53      The Netherlands Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 54      The Netherlands Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 55      The Netherlands Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 56      Rest of Europe Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 57      Rest of Europe Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 58      Rest of Europe Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 59      Rest of Europe Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 60      Asia Pacific Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 61      Asia Pacific Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 62      Asia Pacific Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 63      Asia Pacific Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 64      Asia Pacific Antimicrobial Resistance Surveillance Market Share, By Country, By Value, 2019–2029

Table 65      China Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 66      China Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 67      China Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 68      China Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 69      India Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 70      India Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 71      India Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 72      India Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 73      Japan Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 74      Japan Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 75      Japan Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 76      Japan Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 77      South Korea Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 78      South Korea Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 79      South Korea Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 80      South Korea Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 81      Australia & New Zealand Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 82      Australia & New Zealand Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 83      Australia & New Zealand Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 84      Australia & New Zealand Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 85      Indonesia Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 86      Indonesia Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 87      Indonesia Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 88      Indonesia Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 89      Malaysia Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 90      Malaysia Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 91      Malaysia Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 92      Malaysia Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 93      Singapore Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 94      Singapore Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 95      Singapore Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 96      Singapore Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 97      Vietnam Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 98      Vietnam Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 99      Vietnam Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 100    Vietnam Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 101    Rest of APAC Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 102    Rest of APAC Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 103    Rest of APAC Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 104    Rest of APAC Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 105    Latin America Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 106    Latin America Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 107    Latin America Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 108    Latin America Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 109    Latin America Antimicrobial Resistance Surveillance Market Share, By Country, By Value, 2019–2029

Table 110    Brazil Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 111    Brazil Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 112    Brazil Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 113    Brazil Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 114    Mexico Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 115    Mexico Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 116    Mexico Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 117    Mexico Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 118    Argentina Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 119    Argentina Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 120    Argentina Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 121    Argentina Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 122    Peru Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 123    Peru Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 124    Peru Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 125    Peru Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 126    Rest of LATAM Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 127    Rest of LATAM Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 128    Rest of LATAM Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 129    Rest of LATAM Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 130    Middle East and Africa Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 131    Middle East and Africa Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 132    Middle East and Africa Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 133    Middle East and Africa Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 134    Middle East and Africa Antimicrobial Resistance Surveillance Market Share, By Country, By Value, 2019–2029

Table 135    Saudi Arabia Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 136    Saudi Arabia Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 137    Saudi Arabia Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 138    Saudi Arabia Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 139    UAE Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 140    UAE Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 141    UAE Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 142    UAE Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 143    Qatar Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 144    Qatar Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 145    Qatar Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 146    Qatar Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 147    Kuwait Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 148    Kuwait Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 149    Kuwait Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 150    Kuwait Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 151    South Africa Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 152    South Africa Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 153    South Africa Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 154    South Africa Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 155    Nigeria Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 156    Nigeria Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 157    Nigeria Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 158    Nigeria Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 159    Algeria Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 160    Algeria Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 161    Algeria Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 162    Algeria Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 163    Rest of MEA Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 164    Rest of MEA Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 165    Rest of MEA Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 166    Rest of MEA Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 167    Becton, Dickinson and Company  Overview

Table 168    Becton, Dickinson and Company  Financial Overview

Table 169    Biomerieux  Company Overview

Table 170    Biomerieux  Financial Overview

Table 171    Thermo Fisher Scientific  Company Overview

Table 172    Thermo Fisher Scientific  Financial Overview

Table 173    Danaher  Company Overview

Table 174    Danaher  Financial Overview

Table 175    Luminex Corporation  Company Overview

Table 176    Luminex Corporation  Financial Overview

Table 177    Bruker  Company Overview

Table 178    Bruker  Financial Overview

Table 179    Bio-Rad  Company Overview

Table 180    Bio-Rad  Financial Overview

Table 181    Qiagen Company Overview

Table 182    Qiagen Financial Overview

Table 183    Abbott Laboratories Company Overview

Table 184    Abbott Laboratories Financial Overview

Table 185    Roche Diagnostics Company Overview

Table 186    Roche Diagnostics Financial Overview

Table 187    OpGen, Inc.  Company Overview

Table 188    OpGen, Inc.  Financial Overview

Table 189    Wolters Kluwer N.V.  Company Overview

Table 190    Wolters Kluwer N.V.  Financial Overview

Table 191    Lumed Company Overview

Table 192    Lumed Financial Overview

Table 193    BioSpace Company Overview

Table 194    BioSpace Financial Overview

Table 195    Cepheid Company Overview

Table 196    Cepheid Financial Overview

Market Segmentation

No data available
No data available

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

Note: Please share the corporate email address for faster response

This website is secure and your personal details are safe.

Frequently Asked Questions (FAQs):

Ans: Global Antimicrobial Resistance Surveillance Market size was estimated at USD 5.71 billion in 2022.
Ans: Global Antimicrobial Resistance Surveillance Market size is expected to grow at a CAGR of 5.6% during the forecast period between 2023 and 2029.
Ans: Global Antimicrobial Resistance Surveillance Market size is expected to reach a value of USD 7.92 billion by 2029.
Ans: Major factors driving the growth of the Global Antimicrobial Resistance Surveillance Market include an increasing innovation in diagnostic technologies and growing incidences of hospital-acquired infections.
Ans: North America holds the highest market share in the Global Antimicrobial Resistance Surveillance Market.
Ans: The clinical diagnostics segment accounts for a higher market share in the Global Antimicrobial Resistance Surveillance Market by application.
Ans: The diagnostic kits segment holds the highest market share in the Global Antimicrobial Resistance Surveillance Market by solution.
Ans: Key players in the Global Antimicrobial Resistance Surveillance Market include Becton, Dickinson and Company, Biomerieux, Thermo Fisher Scientific, Danaher, Luminex Corporation, Bruker, Bio-Rad, Qiagen, Abbott Laboratories, Roche Diagnostics, OpGen, Inc., Wolters Kluwer N.V., Lumed, BioSpace, and Cepheid. 
array(1) {
  ["__ci_last_regenerate"]=>
  int(1731029235)
}